STAT3-YAP/TAZ signaling in endothelial cells promotes tumor angiogenesis

2021 ◽  
Vol 14 (712) ◽  
Author(s):  
Ying Shen ◽  
Xiaohong Wang ◽  
Yi Liu ◽  
Mahak Singhal ◽  
Can Gürkaşlar ◽  
...  
2020 ◽  
Author(s):  
Yu Yan ◽  
Qiang Song ◽  
Li Yao ◽  
Liang Zhao ◽  
Hui Cai

Abstract Background:The YAP signaling pathway is altered and implicated as oncogenic in human mammary cancers.However, roles of YAP signaling that regulate the breast tumor angiogenesis have remained elusive. Tumor angiogenesis is coordinated by the activation of both cancer cells and vascular endothelial cells. Whether the YAP signalingpathway can regulate the intercellular interaction between cancer cells and endothelial cellsis essentially unknown.Results: We showed here that conditioned media from YAP overexpressed breast cancer cells (CM-YAP+) could promote angiogenesis, accompanied byincreased tube formation, migration, and proliferation of human umbilical vein endothelial cells (HUVECs). Down regulation of YAP in HUVECs reversed CM-YAP+ induced angiogenesis.CM-YAP+ time-dependently activated YAP inHUVECs by dephosphorylating YAP and increasing nuclear translocation.We also identified that both G13-RhoA and PI3K/Akt signaling pathway were necessary for CM-YAP+ induced activation of YAP.Besides, connective tissue growth factor (CTGF) and angiopoietin-2 (ANG-2)actedas down-stream of YAP in HUVECs to promote angiogenesis.In addition, subcutaneous tumors nude mice model demonstrated that tumors overexpressed YAP revealed moreneovascularization in vivo.Conclusions: YAP-YAP interaction between breastcancer cells and endothelial cellscould promote tumor angiogenesis, supporting that YAP is a potential marker and target fordeveloping novel therapeutic strategies against breast cancer.


2019 ◽  
Vol 26 (4) ◽  
pp. 665-679 ◽  
Author(s):  
Marco B. Schaaf ◽  
Diede Houbaert ◽  
Odeta Meçe ◽  
Patrizia Agostinis

2013 ◽  
Author(s):  
Gerald W. Prager ◽  
Kira Braemswig ◽  
Marina Poettler ◽  
Christoph Zieleinski

2006 ◽  
Vol 118 (9) ◽  
pp. 2350-2358 ◽  
Author(s):  
Sylvie Lamy ◽  
Marcia T. Ruiz ◽  
Jan Wisniewski ◽  
Seema Garde ◽  
Shafaat A. Rabbani ◽  
...  

Cancer Cell ◽  
2003 ◽  
Vol 3 (5) ◽  
pp. 497-509 ◽  
Author(s):  
Anthony S Don ◽  
Oliver Kisker ◽  
Pierre Dilda ◽  
Neil Donoghue ◽  
Xueyun Zhao ◽  
...  

Cancer Cell ◽  
2005 ◽  
Vol 8 (1) ◽  
pp. 13-23 ◽  
Author(s):  
Qinghua Zeng ◽  
Shenglin Li ◽  
Douglas B. Chepeha ◽  
Thomas J. Giordano ◽  
Jong Li ◽  
...  

2007 ◽  
Vol 177 (3) ◽  
pp. 539-549 ◽  
Author(s):  
Mark M. Fuster ◽  
Lianchun Wang ◽  
Janice Castagnola ◽  
Lyudmila Sikora ◽  
Krisanavane Reddi ◽  
...  

To examine the role of endothelial heparan sulfate during angiogenesis, we generated mice bearing an endothelial-targeted deletion in the biosynthetic enzyme N-acetylglucosamine N-deacetylase/N-sulfotransferase 1 (Ndst1). Physiological angiogenesis during cutaneous wound repair was unaffected, as was growth and reproductive capacity of the mice. In contrast, pathological angiogenesis in experimental tumors was altered, resulting in smaller tumors and reduced microvascular density and branching. To simulate the angiogenic environment of the tumor, endothelial cells were isolated and propagated in vitro with proangiogenic growth factors. Binding of FGF-2 and VEGF164 to cells and to purified heparan sulfate was dramatically reduced. Mutant endothelial cells also exhibited altered sprouting responses to FGF-2 and VEGF164, reduced Erk phosphorylation, and an increase in apoptosis in branching assays. Corresponding changes in growth factor binding to tumor endothelium and apoptosis were also observed in vivo. These findings demonstrate a cell-autonomous effect of heparan sulfate on endothelial cell growth in the context of tumor angiogenesis.


Sign in / Sign up

Export Citation Format

Share Document